title: Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.
abstract: Periprosthetic osteolysis is a serious complication of total hip replacement (THR) in the medium to long term. Although often asymptomatic, osteolysis can lead to prosthesis loosening and periprosthetic fracture. These complications cause significant morbidity and require complex revision surgery. Here, we review advances in our understanding of the cell and tissue response to particles produced by wear of the articular and non-articular surfaces of prostheses. We discuss the molecular and cellular regulators of osteoclast formation and bone resorptive activity, a better understanding of which may lead to pharmacological treatments for periprosthetic osteolysis. We describe the development of imaging techniques for the detection and measurement of osteolysis around THR prostheses, which enable improved clinical management of patients, provide a means of evaluating outcomes of non-surgical treatments for periprosthetic osteolysis, and assist in pre-operative planning for revision surgery. Finally, there have been advances in the materials used for bearing surfaces to minimise wear, and we review the literature regarding the performance of these new materials to date.
authors.affiliation: Department of Orthopaedics and Trauma, Royal Adelaide Hospital, Adelaide, Australia.
authors.forename: Donald W
authors.initials: DW
authors.lastname: Howie
authors.forename: Susan D
authors.initials: SD
authors.lastname: Neale
authors.forename: David R
authors.initials: DR
authors.lastname: Haynes
authors.forename: Oksana T
authors.initials: OT
authors.lastname: Holubowycz
authors.forename: Margaret A
authors.initials: MA
authors.lastname: McGee
authors.forename: Lucian B
authors.initials: LB
authors.lastname: Solomon
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Callary
authors.forename: Gerald J
authors.initials: GJ
authors.lastname: Atkins
authors.forename: David M
authors.initials: DM
authors.lastname: Findlay
mesh_terms: D000818:Animals; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects* / Q000639:trends; D001862:Bone Resorption / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D018786:Bone Substitutes / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000276:immunology* / Q000473:pathology / Q000601:surgery; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008264:Macrophages / Q000276:immunology* / Q000378:metabolism; D055595:Mechanical Phenomena; D010010:Osteoclasts / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D010014:Osteolysis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D057068:Periprosthetic Fractures / Q000209:etiology / Q000517:prevention & control*; D010587:Phagocytosis; D011095:Polyethylenes / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D011475:Prosthesis Failure; D013499:Surface Properties; D014057:Tomography, X-Ray Computed; D016474:Weight-Bearing
chemical_list: D018786:Bone Substitutes; D018836:Inflammation Mediators; D011095:Polyethylenes